Compare FNF & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FNF | FMS |
|---|---|---|
| Founded | 1847 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Misc Health and Biotechnology Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0B | 14.2B |
| IPO Year | 2005 | N/A |
| Metric | FNF | FMS |
|---|---|---|
| Price | $50.57 | $23.24 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 2 | 2 |
| Target Price | ★ $60.50 | $30.00 |
| AVG Volume (30 Days) | ★ 1.7M | 436.8K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.18% | 2.44% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.21 | N/A |
| Revenue | ★ $14,445,000,000.00 | N/A |
| Revenue This Year | $10.90 | N/A |
| Revenue Next Year | $5.44 | $3.83 |
| P/E Ratio | $22.53 | ★ $15.62 |
| Revenue Growth | ★ 5.58 | N/A |
| 52 Week Low | $42.78 | $20.96 |
| 52 Week High | $65.33 | $30.46 |
| Indicator | FNF | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 64.24 | 54.20 |
| Support Level | $42.78 | $22.50 |
| Resistance Level | $60.63 | $23.36 |
| Average True Range (ATR) | 1.16 | 0.38 |
| MACD | 0.67 | 0.07 |
| Stochastic Oscillator | 99.09 | 69.05 |
Fidelity National Financial Inc is a provider of (i) title insurance, escrow and other title-related services, including trust activities, trustee sales guarantees, recordings and reconveyances and home warranty and (ii) transaction services to the real estate and mortgage industries. It operates in three segments: Title, F&G, Corporate and Other. The title segment that derives the majority of revenue consists of the operations of title insurance underwriters and related businesses, which provide title insurance and escrow and other title-related services including trust activities, trustee sales guarantees, and home warranty products. All of the company's revenue is generated in the United States.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.